BioCentury
ARTICLE | Clinical News

AngioGenex preclinical data

February 9, 2009 8:00 AM UTC

Data from a xenograft mouse model of cancer showed that 30 mg/kg AGX-8 produced 41% tumor inhibition compared to saline control (p<0.01). AGX-8 is an inhibitor of DNA binding 1 (Id1) inhibitor. Data ...